Gerresheimer issues a EUR 300 million corporate bond

Refinancing concluded

Düsseldorf, May 12, 2011 – Gerresheimer AG today successfully placed a EUR 300 million corporate bond. The bond (ISIN XS0626028566) with a term of seven years has an interest rate of 5.00 percent, the issue price is 99.40 percent. Due to the high amount of interest from institutional investors and retail intermediaries all over Europe the bond was over-subscribed several times.

The proceeds from the bond will be used to repay existing bank debt and for general corporate financing purposes. The bond’s listing on the Luxembourg Stock Exchange is scheduled for May 19, 2011. Commerzbank, Deutsche Bank, Royal Bank of Scotland and UniCredit, were joint lead managers of the transaction.

“The successful bond issuance confirms how attractive our business model is to the capital markets. With this we have a long-term and balanced financing structure in place”, commented Hans-Jürgen Wiecha, CFO of Gerresheimer AG.

The placement of the bond concludes the refinancing process that Gerresheimer commenced early at the beginning of March 2011 on the back of the positive market environment and the rating agencies’ upgrade of its rating.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.

Our Group realizes revenues of around one billion Euros and has 10,000 employees at 45 locations in Europe, North and South America and Asia. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.

Contact  
Jens Kürten
Director Corporate Communication & Marketing  
Phone +49 211 6181-250  
Fax +49 211 6181-241  
E-Mail: please click